Table 5 RT-qPCR analysis of PSB and BALF samples obtained from patients in the HS, stable COPD and AECOPD groups
n (%) | HS | Stable COPD patients | AECOPD patients | |||
|---|---|---|---|---|---|---|
(n = 33) | (n = 34) | (n = 32) | ||||
PSB | BALF | PSB | BALF | PSB | BALF | |
Staphylococcus aureus | 3 (9.1) | 2 (6.1) | 16 (47.1) | 17 (50.0) | 22 (68.8) | 20 (62.5) |
Klebsiella pneumoniae | 5 (15.2) | 6 (18.2) | 10 (29.4) | 9 (26.5) | 15 (46.9) | 16 (50.0) |
Streptococcus pneumoniae | 10 (30.3) | 8 (24.2) | 20 (58.8) | 18 (52.9) | 14 (42.8) | 17 (53.1) |
Pseudomonos aeruginosa | 2 (6.1) | 2 (6.1) | 15 (44.1) | 17 (50.0) | 20 (62.5) | 23 (71.9) |
Haemophilus influenzeae | 5 (15.2) | 6 (18.2) | 18 (52.9) | 20 (58.8) | 25 (78.1) | 24 (75.0) |
Moraxella catarrhalis | 4 (12.1) | 4 (12.1) | 22 (64.7) | 20 (58.8) | 16 (50.0) | 15 (46.9) |